0.2 |
1.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 |
0.5 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
0.1 |
0.4 |
GO:0002605 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.1 |
0.3 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
0.1 |
0.3 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
0.1 |
0.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
0.1 |
0.3 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 |
0.4 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
0.0 |
0.2 |
GO:0071484 |
response to high light intensity(GO:0009644) cellular response to light intensity(GO:0071484) |
0.0 |
0.1 |
GO:0061010 |
cardiac cell fate determination(GO:0060913) gall bladder development(GO:0061010) |
0.0 |
0.2 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.0 |
0.2 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 |
0.3 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
0.0 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
0.0 |
0.1 |
GO:0061030 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 |
0.4 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 |
0.1 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.0 |
0.3 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
0.0 |
0.3 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 |
0.1 |
GO:0039017 |
vestibulocochlear nerve formation(GO:0021650) pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
0.0 |
0.3 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 |
0.0 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) positive regulation of NK T cell differentiation(GO:0051138) |
0.0 |
0.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.0 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 |
0.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
0.0 |
0.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.0 |
0.1 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 |
0.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |